Speaking Engagements
 
Email Page
Legal and IP Strategies to Strengthen Biosimilar Medicine Developers
November 1, 2017

Axinn partner Stacie Ropka participated in a panel discussion at the World Biosimilar Congress Europe conference in Basel, Switzerland. "Legal and IP Strategies to Strengthen Biosimilar Medicine Developers" addressed the following topics: